Cyclosporine is an effective short-term therapy for parthenium dermatitis, but relapse is frequent after abrupt withdrawal. Tapering or transitioning to steroid-sparing agents may enhance long-term control. Reduction in IL-6 highlights its role in disease pathogenesis and response to immunosuppression.
Verma et al. (Tue,) studied this question.